# An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)

> **NCT02856230** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 30 (actual)

## Conditions studied

- Lower Limb Ischemia
- Peripheral Vascular Diseases

## Interventions

- **DEVICE:** Ranger SL DEB

## Key facts

- **NCT ID:** NCT02856230
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-05
- **Final completion:** 2018-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02856230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02856230, "An Efficacy and Safety Study to Evaluate Ranger DEB for BTK Angioplasty in Patients With CLI (RANGER-BTK)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02856230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*